Merge Healthcare buys Confirma
This article was originally published in The Gray Sheet
Executive Summary
Health IT provider Merge Healthcare enters the computer-aided detection (CAD) market through its $22 million stock-swap acquisition of Confirma. Under a definitive agreement announced Aug. 6, Merge gains privately-held Confirma's flagship CADstream system, which combines magnetic resonance imaging technology with CAD to detect breast and prostate cancers. CAD technology "is still at an early adoption phase in the market for most indications, but it has significant opportunity as a tool for reducing imaging costs in today's health care reform environment," Merge Healthcare CEO Justin Dearborn explains. Confirma investors will own about 8.5% of Merge after the deal closes in September